11:25am ET
Health and Healthcare
Monday’s 3 Major Biopharma Movers
On Monday morning, Merck, Mylan and Bristol-Myers Squibb made substantial runs, either up or down.
Companies
/Healthcare
Bristol-Myers Squibb Company
$63.06
▲ $0.22 (+0.35%) today
Markets closed · 3:43am ET
BMY Coverage
Page 25
4:04pm ET
Investing
Wells Fargo, Bristol-Myers Drop in on Monday’s 52-Week Low Club
October 3, 2016: Here are four stocks trading with relatively heavy volume among 29 equities making new 52-week lows in Monday’s session. Wells Fargo & Co. (NYSE: WFC) lost about 1.6% Monday…
4:04pm ET
Investing
Bristol-Myers, Abercrombie & Fitch Slide into Wednesday’s 52-Week Low Club
September 28, 2016: Here are four stocks trading with relatively heavy volume among 33 equities making new 52-week lows in Wednesday’s session. NYSE advancers led decliners by nearly 7 to 3 and…
7:40am ET
Health and Healthcare
Major Pharma Continues to See Rising Tide in Short Interest
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
10:25am ET
Health and Healthcare
Jefferies Issues Top Pharma and Biohealth Stocks to Buy
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
7:25am ET
Health and Healthcare
Major Pharma Continues to See Significant Drop in Short Interest
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
4:04pm ET
Investing
Kroger, Whole Foods in Monday’s 52-Week Low Club
September 12, 2016: Here are four stocks trading with relatively heavy volume among 56 equities making new 52-week lows in Monday’s session. NYSE advancers led decliners by more than 2 to 1…
4:04pm ET
Investing
Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club
September 2, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Friday’s session. NYSE advancers led decliners by nearly 4 to 1 and…
8:45am ET
Health and Healthcare
Major Pharma Short Interest Faces Significant Drop
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
9:05am ET
Health and Healthcare
Major Pharma Short Interest Slides
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
12:45pm ET
Health and Healthcare
Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further
Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise estimates for Bristol-Myers.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More
The top analyst upgrades, downgrades and initiations seen on Monday morning include BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto and Twenty-First Century Fox.
10:35am ET
Health and Healthcare
Why Bristol-Myers Failure Is a Huge Win for Merck
Bristol-Myers Squibb shares took a nosedive early Friday's following an update in its late-stage Checkmate trial. But Bristol-Myer's failure was a big win for Merck.
9:45am ET
Health and Healthcare
Bristol-Myers Earnings Don’t Appear to Be Enough for Investors
Bristol-Myers Squibb released a better-than-expected second-quarter earnings report before the markets opened on Thursday.
8:25am ET
Health and Healthcare
Short Sellers Get Selective on Major Pharma
The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest was mixed.